Icscs201 Cipla Pharmaceuticals Export Data

As of 2026-10-03, Icscs201 Cipla Pharmaceuticals is recorded in global trade data on TradeInt, exporting goods to UNITED STATES. Its bill of lading records cover products such as PHARMACEUTICALS HARMLESS MEDICINES 2632 CARTONS IN 36 PACKAGES NET WT 7573.080 KGS OTHER DETAILS AS PER ATTACHED ANNEXURE TEMPERATURE TO BE SET AT 20.0 CPHARMACEUTICALS HARMLESS MEDICINES 3004 CARTONS IN 36 PACKAGES NET WT 9127.755 KGS OTHER DETAILS AS PER ATTACHED ANNEXURE TEMPERATURE TO BE SET AT 20.0 CPHARMACEUTICALS HARMLESS MEDICINES 4077 CARTONS IN 35 PACKAGES NET WT 7729.555 KGS OTHER DETAILS AS PER ATTACHED ANNEXURE TEMPERATURE TO BE SET AT 20.0 CPHARMACEUTICALS HARMLESS MEDICINES 2363 CARTONS IN 36 PACKAGES NET WT 7709.843 KGS OTHER DETAILS AS PER ATTACHED ANNEXURE TEMPERATURE TO BE SET AT 20.0 CPHARMACEUTICALS HARMLESS MEDICINES 3393 CARTONS IN 36 PACKAGES NET WT 5242.185 KGS OTHER DETAILS AS PER ATTACHED ANNEXURE TEMPERATURE TO BE SET AT 20.0 C, PHARMACEUTICALS HARMLESS MEDICINES 2626 CART ONS IN 37 PACKAGES NET WT 6701.552 KGS OTHER DETAILS AS PER ATTACHED ANNEXURE TEMPERATUR E TO BE SET AT 21.0 CPHARMACEUTICALS HARMLESS MEDICINES 2652 CART ONS IN 37 PACKAGES NET WT 6587.568 KGS OTHER DETAILS AS PER ATTACHED ANNEXURE TEMPERATUR E TO BE SET AT 21.0 CPHARMACEUTICALS HARMLESS MEDICINES 3500 CART ONS IN 38 PACKAGES NET WT 7516.748 KGS OTHER DETAILS AS PER ATTACHED ANNEXURE TEMPERATUR E TO BE SET AT 21.0 CPHARMACEUTICALS HARMLESS MEDICINES 2840 CART ONS IN 38 PACKAGES NET WT 6926.300 KGS OTHER DETAILS AS PER ATTACHED ANNEXURE TEMPERATUR E TO BE SET AT 21.0 C and PHARMACEUTICALS HARMLESS MEDICINES 2807 CART ONS IN 38 PACKAGES DICLOFENAC SODIUM TOPICAL GEL 1WW INV.NO.6001345030 DATE 04.08.2020 HS CODE NOS. 30049069 TOTAL NET WT9257.045 KGS TEMPERATURE TO BE SET AT 21.0 CPHARMACEUTICALS HARMLESS MEDICINES 3185 under HS codes 700232 and 300432. Each record includes the exporter, importer, country of origin, destination country, trade value, weight, quantity, and ports of loading and discharge.